These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19084843)

  • 1. Topiramate weight loss in migraine patients.
    Alberici A; Borroni B; Manelli F; Griffini S; Zavarise P; Padovani A; Dalla Volta G
    J Neurol Sci; 2009 Mar; 278(1-2):64-5. PubMed ID: 19084843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight reducing and metabolic effects of topiramate in patients with migraine--an observational study.
    Schütt M; Brinkhoff J; Drenckhan M; Lehnert H; Sommer C
    Exp Clin Endocrinol Diabetes; 2010 Jul; 118(7):449-52. PubMed ID: 20200812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weight regain after discontinuation of topiramate treatment in patients with migraine: a prospective observational study.
    Verrotti A; Parisi P; Agostinelli S; Loiacono G; Marra F; Coppola G; Pisani LR; Gorgone G; Striano P; Pisani F; Belcastro V
    CNS Drugs; 2015 Feb; 29(2):163-9. PubMed ID: 25655110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topiramate vs divalproex sodium in the preventive treatment of migraine: a prospective "real-world" study.
    Krymchantowski AV; Jevoux CC
    Headache; 2011 Apr; 51(4):554-8. PubMed ID: 21457240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate-induced weight loss: a review.
    Verrotti A; Scaparrotta A; Agostinelli S; Di Pillo S; Chiarelli F; Grosso S
    Epilepsy Res; 2011 Aug; 95(3):189-99. PubMed ID: 21684121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 levels in migraine patients receiving topiramate.
    Koçer A; Memişoğullari R; Domaç FM; Ilhan A; Koçer E; Okuyucu S; Ozdemir B; Yüksel H
    Pain Pract; 2009; 9(5):375-9. PubMed ID: 19622115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment.
    Brown JS; Papadopoulos G; Neumann PJ; Friedman M; Miller JD; Menzin J
    Headache; 2005 Sep; 45(8):1012-22. PubMed ID: 16109115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of topiramate 200 mg/d in the prevention of migraine with/without aura in adults: a randomized, placebo-controlled, double-blind, 12-week pilot study.
    Silberstein SD; Hulihan J; Karim MR; Wu SC; Jordan D; Karvois D; Kamin M
    Clin Ther; 2006 Jul; 28(7):1002-11. PubMed ID: 16990078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of topiramate use on body composition and resting metabolic rate in migraine patients.
    Yaman M; Ucok K; Demirbas H; Genc A; Oruc S; Karabacak H; Koyuncu G
    Neurol Sci; 2013 Feb; 34(2):225-9. PubMed ID: 22391675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topiramate improves health-related quality of life when used to prevent migraine.
    Diamond M; Dahlöf C; Papadopoulos G; Neto W; Wu SC
    Headache; 2005 Sep; 45(8):1023-30. PubMed ID: 16109116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate, nutrition and weight change: a prospective study.
    Klein KM; Theisen F; Knake S; Oertel WH; Hebebrand J; Rosenow F; Hamer HM
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):590-3. PubMed ID: 18077476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of weight loss in adults with topiramate-treated epilepsy.
    Ben-Menachem E; Axelsen M; Johanson EH; Stagge A; Smith U
    Obes Res; 2003 Apr; 11(4):556-62. PubMed ID: 12690085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topiramate in migraine prophylaxis: long-term impact on resource utilization and cost.
    Silberstein SD; Feliu AL; Rupnow MF; Blount AC; Boccuzzi SJ
    Headache; 2007 Apr; 47(4):500-10. PubMed ID: 17445099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topiramate (Topamax) for prevention of migraine.
    Med Lett Drugs Ther; 2005 Jan; 47(1201):9-10. PubMed ID: 15678014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine.
    Mei D; Ferraro D; Zelano G; Capuano A; Vollono C; Gabriele C; Di Trapani G
    Clin Neuropharmacol; 2006; 29(5):269-75. PubMed ID: 16960472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum uric acid and lipid levels while taking topiramate for migraine.
    Koçer A; Dikici S; Atakay S; Okuyucu S
    Headache; 2008 Jul; 48(7):1056-60. PubMed ID: 18179568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose topiramate plus sodium divalproate for positive responders intolerant to full-dose monotherapy.
    Krymchantowski AV; Jevoux Cda C
    Headache; 2012 Jan; 52(1):129-32. PubMed ID: 22085390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.
    Bays H
    Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1777-801. PubMed ID: 20707765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight loss of 172 lb with topiramate in a patient with migraine headaches.
    Khandalavala B; Spangler M
    Am J Health Syst Pharm; 2012 Mar; 69(5):367-8. PubMed ID: 22345412
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.